Cingulate Inc. Made Headway
Fri, Feb 24, 2023 at 07:13 PM
Cingulate Inc. (CING:NASDAQ) shot up at $1.56, a gain of 43.1%. On Fri, Feb 24, 2023, CING:NASDAQ touched a New 2-Week High of $1.56. The stock appeared on our News Catalysts scanner on Fri, Feb 24, 2023 at 07:54 AM in the 'MISCELLANEOUS' category. From Mon, Feb 13, 2023, the stock recorded 37.50% Up Days and 33.33% Green Days
About Cingulate Inc. (CING:NASDAQ)
Cingulate Inc is a clinical stage biopharmaceutical company utilizing its proprietary precision timed release drug delivery platform to build and advance a pipeline of next-generation pharmaceutical...
Top 10 Gainers:
- Bridger Aerospace Group Holdings Inc. (BAER:NASDAQ), 78.73%
- CYREN Ltd. (CYRN:NASDAQ), 61.9%
- Connexa Sports Technologies Inc. (CNXA:NASDAQ), 49.43%
- Cingulate Inc. (CING:NASDAQ), 43.12%
- Decarbonization Plus Acquisition Corporation IV (DCRD:NASDAQ), 40.52%
- Timber Pharmaceuticals Inc. (TMBR:NYSEMKT), 37.31%
- Avita Medical Limited (RCEL:NASDAQ), 36.53%
- OncoSec Medical Incorporated (ONCS:NASDAQ), 28.71%
- Danimer Scientific Inc. (DNMR:NYSE), 27.5%
- Nuburu Inc. (BURU:NYSEMKT), 26.52%